Agent Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
59
- Portfolio
-
22
- Exits
-
19
Agent Capital General Information
Company Description
Founded in 2017, Agent Capital is a venture capital firm based in Waltham, Massachusetts. The firm seeks to invest in the healthcare sector in early-and later-stage financings. The firm mainly focuses on immunology, neuroscience, oncology, ophthalmology, and rare diseases. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.agentcapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 1400 Main Street
- Floor 1
- Waltham, MA 02451
- United States
Agent Capital Investments (59)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Star Therapeutics | 23-Oct-2026 | Later Stage VC | Biotechnology | Generating Revenue | ||
| Primrose Bio | 22-Sep-2026 | Biotechnology | Generating Revenue | |||
| Flare Therapeutics | 30-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Alveus Therapeutics | 24-Feb-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| ViTToria Biotherapeutics | 21-Jan-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Sundance BioSciences | 01-Jan-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| TRexBio | 13-Nov-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Star Therapeutics | 22-Sep-2025 | Biotechnology | Generating Revenue | |||
| Nu-Tek BioSciences | 14-Jul-2025 | Later Stage VC | Biotechnology | Generating Revenue | ||
| GlycoEra | 27-May-2025 | Later Stage VC | Biotechnology | Clinical Trials - Phase 1 |
Agent Capital Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Affini-T | 10-Oct-2026 | Out of Business | |
| TRexBio | 09-Oct-2026 | ||
| Freenome | 20-Jul-2026 | ||
| Immunitas Therapeutics | 12-May-2026 | ||
| ImCheck Therapeutics | 15-Dec-2025 | ||
| Orbital Therapeutics | 08-Dec-2025 | ||
| Foresight Diagnostics | 04-Dec-2025 | ||
| Interius BioTherapeutics | 14-Oct-2025 | ||
| Zenas BioPharma | 13-Sep-2024 | IPO | |
| Metagenomi Therapeutics | 09-Feb-2024 | IPO |
Agent Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Agent Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Agent Capital Co-Investors (167)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 3 |
|
|
||
| Casdin Capital |
|
|
|||
| Catalio Capital Management |
|
|
|||
| Double Point Ventures |
|
|
|||
| Tellus BioVentures |
|
|
Agent Capital FAQs
-
What is Agent Capital?
Founded in 2017, Agent Capital is a venture capital firm based in Waltham, Massachusetts.
-
When was Agent Capital founded?
Agent Capital was founded in 2017.
-
Where is Agent Capital headquartered?
Agent Capital is headquartered in Waltham, MA.
-
What is Agent Capital's total asset value?
Agent Capital has around in total assets under management.
-
How many investments has Agent Capital made?
Agent Capital has made 59 investments.
-
What has Agent Capital invested in?
Agent Capital has made numerous investments in companies like Star Therapeutics, Primrose Bio, and Flare Therapeutics within the Biotechnology and Drug Discovery industries.
-
What has Agent Capital invested in recently?
Agent Capital's latest investment was on 23-Oct-2026 in Star Therapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
